| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Chief Operating Officer and Chief Legal Officer | Common Stock | 126K | $131K | $1.04 | Nov 4, 2024 | Direct |
| AN2 Therapeutics, Inc. | Chief Operating Officer and Chief Legal Officer | Stock Option (right to buy) | 63K | Nov 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Nov 4, 2024 | 2 | $0 | 4 | Nov 5, 2024 | Chief Operating Officer and Chief Legal Officer |
| ANTX | AN2 Therapeutics, Inc. | Jul 10, 2024 | 1 | $0 | 4 | Jul 12, 2024 | Chief Legal Officer |
| ANTX | AN2 Therapeutics, Inc. | Mar 15, 2024 | 1 | $0 | 4/A | Mar 29, 2024 | Chief Legal Officer |
| ANTX | AN2 Therapeutics, Inc. | Mar 15, 2024 | 2 | $0 | 4 | Mar 18, 2024 | Chief Legal Officer |
| ANTX | AN2 Therapeutics, Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chief Legal Officer |
| ANTX | AN2 Therapeutics, Inc. | Oct 14, 2022 | 1 | $0 | 4 | Oct 28, 2022 | Chief Legal Officer |
| ANTX | AN2 Therapeutics, Inc. | Sep 29, 2022 | 0 | $0 | 3 | Oct 5, 2022 | General Counsel, Chief Legal Officer and Corporate Secretary Exhibit 24 - Power of Attorney |